OSI Systems, Inc.

OSI Systems, Inc. (OSIS) Market Cap

OSI Systems, Inc. has a market capitalization of $4.82B.

Financials based on reported quarter end 2025-12-31

Price: $292.52

-4.32 (-1.46%)

Market Cap: 4.82B

NASDAQ · time unavailable

CEO: Ajay Mehra

Sector: Technology

Industry: Hardware, Equipment & Parts

IPO Date: 1997-10-02

Website: https://www.osi-systems.com

OSI Systems, Inc. (OSIS) - Company Information

Market Cap: 4.82B · Sector: Technology

OSI Systems, Inc. designs and manufactures electronic systems and components worldwide. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation detection, and explosive and narcotics trace detection systems under the Rapiscan Systems, AS&E, and Gatekeeper names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.

Analyst Sentiment

79%
Strong Buy

Based on 17 ratings

Analyst 1Y Forecast: $284.83

Average target (based on 2 sources)

Consensus Price Target

Low

$292

Median

$294

High

$295

Average

$294

Potential Upside: 0.3%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 OSI SYSTEMS INC (OSIS) — Investment Overview

🧩 Business Model Overview

OSI Systems, Inc. (NASDAQ: OSIS) is a diversified designer and manufacturer of specialized electronic systems and components, primarily serving the security, healthcare, and optoelectronics markets. The company’s core business is built on advanced technology integration, utilizing engineering expertise to deliver critical products and solutions for safety, inspection, and diagnostics. OSI Systems maintains a vertically integrated approach, operating through three primary segments: Security, Healthcare, and Optoelectronics & Manufacturing. In the Security segment, the company is a major provider of security and inspection systems, including baggage and cargo screening products used in airports, ports, border crossings, and critical infrastructure worldwide. Its Healthcare division, under the Spacelabs brand, provides patient monitoring, anesthesia delivery, and diagnostic cardiology equipment to hospitals and clinics. Lastly, the Optoelectronics & Manufacturing segment manufactures sensors, lasers, and electronics for both internal use and external customers across diverse industrial applications. OSI Systems benefits from long customer relationships and a significant installed equipment base, often generating recurring revenue from service, software, and consumables. The company’s solutions are known for their regulatory compliance and technological reliability, supporting mission-critical environments.

💰 Revenue Streams & Monetisation Model

OSI Systems’ revenue is diversified across three principal business lines: - Security: Sales of security screening equipment (e.g., X-ray, cargo and baggage scanners, explosive trace detection) constitute a significant portion of overall revenue. Service contracts, maintenance, software updates, and training services provide ongoing, higher-margin recurring revenue. Contract awards from government agencies and airports often span multiple years, contributing predictability and visibility. - Healthcare: The company earns revenue through direct sales of patient monitoring systems, diagnostic cardiology devices, and anesthesia systems. Additional monetization includes long-term service agreements, software licensing, and provision of consumable supplies. - Optoelectronics & Manufacturing: This segment sells optoelectronic devices and components to third-party OEMs as well as to OSI’s own product lines. The business model features both custom and standard product offerings, allowing for tailored solutions and scalability. Across all segments, the company leverages both direct and indirect channels and benefits from multi-year contracts, recurring service income, and integration of hardware with proprietary software.

🧠 Competitive Advantages & Market Positioning

OSI Systems holds several defensible competitive advantages: - Technological Differentiation: The company invests extensively in R&D to maintain advanced capabilities in threat detection, imaging, and medical monitoring. Its proprietary technologies and certifications are key barriers to entry, especially in regulated end markets. - Regulatory Approvals and Certifications: OSI’s systems meet stringent regulatory standards, allowing participation in large-scale government procurement processes globally. Attaining and maintaining these certifications is resource-intensive, deterring smaller competitors. - Diversified and Loyal Customer Base: With thousands of installations worldwide, OSI enjoys deeply embedded customer relationships and high switching costs. The critical nature of its products, particularly in security and healthcare, further reinforces customer stickiness. - Global Manufacturing Footprint: The company’s vertically integrated manufacturing capabilities offer cost advantages and supply chain control, essential for custom and high-reliability products. - Brand Recognition: Through brands like Rapiscan (security) and Spacelabs (healthcare), OSI is recognized for reliability and regulatory compliance. In terms of competitive landscape, OSI faces competition from global conglomerates (such as Smiths Group in security and Philips/GE in healthcare monitoring) but stands out due to its niche market focus, agility, and integrated offerings.

🚀 Multi-Year Growth Drivers

Several structural and emerging trends support OSI Systems’ long-term growth trajectory: - Global Security Spending: Ongoing and rising threats from terrorism, trafficking, and pandemics drive increased investment by governments and transport authorities in advanced screening and detection infrastructure. - Infrastructure Modernization: Initiatives at airports, border crossings, and ports continue to prioritize state-of-the-art security solutions, representing multi-year equipment replacement cycles for OSI’s products. - Healthcare Digitization and Monitoring: The shift toward greater patient monitoring, remote diagnostics, and hospital workflow automation is boosting demand for Spacelabs’ portfolio, with international market expansion representing further upside. - Recurring Revenue Expansion: Service, software, and consumables revenue streams are becoming a larger portion of the mix, supporting margin stability and reducing volatility. - Emerging Markets Penetration: Economic development and regulatory upgrades in regions across Asia, the Middle East, and Latin America are opening new markets for both security and healthcare offerings. - Innovation and Product Pipeline: Continuous roll-out of new detection technology, advanced analytics, and integrated healthcare systems are enabling OSI to address evolving customer needs and regulatory standards.

⚠ Risk Factors to Monitor

Investors should remain vigilant to several key risk areas: - Reliance on Government Contracts: A substantial portion of OSI’s security segment revenue is derived from government contracts, which can be subject to political, funding, regulatory, and procurement changes. Delays or cancellations may adversely impact results. - Technology Obsolescence: Rapid advances in detection and medical technologies require sustained R&D investment. Failure to innovate could erode market share. - Geopolitical and Trade Risks: The company operates globally, so is exposed to tariffs, trade restrictions, regulatory hurdles, and geopolitical tensions, especially given the sensitive nature of its security products. - Regulatory Compliance: Non-compliance or product failures can result in costly recalls, loss of certifications, litigation, or reputational damage, particularly in healthcare. - Customer Concentration: While diversified, key contracts or customers represent significant revenue share at times, potentially creating volatility if relationships are lost or contracts are not renewed. - Foreign Currency Exposure: With international operations and sales, the company is subject to exchange rate fluctuations.

📊 Valuation & Market View

OSI Systems is generally valued as a mid-cap industrial technology provider, balancing steady cash flow with cyclical demand patterns. Its valuation multiples (such as EV/EBITDA and P/E) often fall in line with, or at a premium to, peer companies due to higher margins and recurring revenue growth. The company possesses considerable optionality — expansion of higher-margin service businesses, margin improvement through vertical integration, and international market penetration all support multiple expansion. Analysts tend to view the company’s long-term revenue visibility, healthy balance sheet, and disciplined capital allocation favorably. The market recognizes the combination of defensive characteristics, technology leadership, and ability to capitalize on secular global trends. Occasional lumpiness in contract wins and macro headwinds are balanced by recurring revenue streams and backlog.

🔍 Investment Takeaway

OSI Systems represents a compelling blend of defensive and growth attributes within the industrial technology universe. Its strong market positions in security, healthcare, and optoelectronics are underpinned by proprietary technology, regulatory expertise, and a robust installed base that enables recurring revenue streams. Structural tailwinds, such as increased global security spending, healthcare monitoring adoption, and infrastructure modernization, supply multi-year opportunities for expansion. While exposure to government procurement cycles and the imperative for technological innovation introduce risks, OSI’s diversified business mix, proven execution, and vertical integration help mitigate these concerns. The company’s valuation reflects both its stable cash-generating core segments and the potential for higher-margin growth in services and emerging markets. Long-term investors seeking exposure to mission-critical technology linked to global security and healthcare themes may find OSI Systems’ differentiated positioning and balanced risk/reward profile attractive within a diversified portfolio.

⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

Management delivered strong topline and EPS in Q2 (revenue $464M, +11% YoY; non-GAAP EPS $2.58) with solid cash generation ($62M operating cash flow; DSO -17% QoQ) and positive Opto momentum (Opto +100 bps margin to 12.9%, book-to-bill >1). However, the Q&A pressure focused on Security order softness despite an unchanged ~$1.8B backlog: bookings were described as “pushed to the right” due to the U.S. shutdown and international timing rather than demand collapse, and the company maintained revenue guidance while conceding a Q3 headwind >$50M YoY driven by Mexico comps. The crux for investors is timing: management claims Q4 will be much stronger as Mexico subsides and service revenue remains higher-margin. Meanwhile, guidance confidence is tempered by explicit acknowledgment that tariffs/government shutdowns/backlog conversion timing are hard to predict—yet the answer framing stays optimistic on margin expansion in Q4 and beyond.

AI IconGrowth Catalysts

  • Security: $20 million award to deliver a comprehensive radiological threat detection solution (international customer) using a wide-area continuous monitoring network
  • Security/RF: Selected for Shield (Golden Dome support) IDIQ — $151 billion ceiling value over 10 years; delivery orders expected in the foreseeable future
  • Security/RF: International naval order valued at approximately $30 million for advanced RF-based communication/surveillance for naval operations
  • Opto: Broad demand across diversified customer base; Opto book-to-bill > 1 and Q2 revenue record

Business Development

  • Security: Selected to support security screening at a major global sporting event in Europe this winter (announcement referenced as after-quarter notice)
  • RF: Golden Dome / Missile defense agency contract (“Shield” IDIQ) as part of the U.S. initiative to create an integrated missile defense system
  • Optoelectronics supply chain: OEMs diversifying away from China and derisking supply chains by shifting to other low-cost manufacturing regions (Mexico + Southeast Asia/India/North America execution)

AI IconFinancial Highlights

  • Revenue: $464 million in Q2, +11% YoY; Security +15% YoY to $335 million; Opto +12% YoY to $113 million (new Q2 record for the division)
  • Non-GAAP adjusted EPS: $2.58 in Q2 (Q2 records across multiple metrics)
  • Security Mexico contracts: revenues decreased 50% to $27 million from $54 million (same quarter prior year); management notes Mexico is a major comp headwind
  • Gross margin: 33% in Q2 FY26, down vs prior-year Q2 (mix shift; product vs services), with the company noting FX, tariffs, and supply chain costs as margin drivers
  • Operating expenses: $70.2 million, down 1% YoY; SG&A % of sales improved to 15.1% from 16.8%
  • Tax: GAAP effective tax rate 19.5% (vs 23.3% YoY). Normalized effective tax rate for non-GAAP EPS: ~23.3% (vs 24.0% YoY)
  • Adjusted operating margins: Security 17.8% (down vs 19.9% YoY); Opto increased +100 bps to 12.9% from 12.8%
  • Operating cash flow: $62 million in Q2; DSO decreased 17% from Q1
  • Guidance raised (non-GAAP EPS): fiscal 2016 to $10.30–$10.55 diluted (10%–13% YoY growth) while maintaining revenue guidance
  • Q3 revenue headwind: expected Q3 revenue variance >$50 million YoY, with Mexico comp the primary driver; management expects stronger growth in Q4 vs Q3

AI IconCapital Funding

  • Convertible notes: raised $575 million in November at a 0.5% coupon
  • Share buyback: repurchased ~547,000 shares at average price $267 per share (Q2 referenced as ~546,000 shares)
  • Leverage: net leverage ~2.2x at end of Q2 (per credit agreement calculation)

AI IconStrategy & Ops

  • RF capacity expansion: expanding into new facilities in Texas to increase production capacity and improve operational efficiency
  • Opto capacity/footprint: adding newest manufacturing facility in Mexico and leveraging operations across Southeast Asia, India, and North America to meet demand
  • Healthcare: described as a challenging quarter; management intensified sales efforts and focused pipeline on next-generation product development (timeline to regain footing: 'will take time')
  • Operational mitigation for bookings timing: continued to manage revenue guidance prudently amid delayed orders (government shutdown + international customer pushouts)

AI IconMarket Outlook

  • Security bookings: lower than expected during the quarter; backlog essentially unchanged at $1.8 billion (management framed as timing/pushout rather than demand collapse)
  • Back-half conversion expectation: management expects a strong next 6 months following pushouts
  • FY26 cadence: Q3 expected to be weaker YoY by >$50 million due to Mexico comp; Q4 expected to be significantly stronger as backlog conversion timing normalizes

AI IconRisks & Headwinds

  • Security bookings softer than expected: attributed to U.S. government shutdown delaying anticipated orders and some pushout from international customers; however, management stated high-probability opportunities remain 'very much alive' in the pipeline
  • Macro/timing uncertainty: management explicitly noted timing of backlog conversion, new bookings, and cash collections can vary materially; impact of tariffs and potential future government shutdowns is difficult to predict
  • Mexico receivables/cash flow driver: still the largest receivable at the company level; while collections improved in Q2, outsized free-cash-flow conversion is expected as Mexico receivable normalizes through fiscal 2026 and into part of fiscal 2027 (potential risk if collection timing slips)
  • Margin headwind from Mexico product/service mix: management acknowledged inherent operational efficiency from repeating manufacturing the same product drove margin benefits historically, but coming into the year they expected a Mexico-related margin headwind; after Q3, margin headwind subsides

Sentiment: MIXED

Note: This summary was synthesized by AI from the OSIS Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (OSIS)

© 2026 Stock Market Info — OSI Systems, Inc. (OSIS) Financial Profile